TY - JOUR
T1 - HPV vaccine coverage among men who have sex with men - National HIV Behavioral Surveillance System, United States, 2011
AU - for the NHBS study group
AU - Meites, Elissa
AU - Markowitz, Lauri E.
AU - Paz-Bailey, Gabriela
AU - Oster, Alexandra M.
AU - White, Jianglan
AU - Todd, Jeff
AU - Bautista, Greg
AU - Flynn, Colin
AU - German, Danielle
AU - Miminos, Maura
AU - Doherty, Rose
AU - Wittke, Chris
AU - Prachand, Nikhil
AU - Benbow, Nanette
AU - Melville, Sharon
AU - Sheu, Shane
AU - Novoa, Alicia
AU - Thrun, Mark
AU - Al-Tayyib, Alia
AU - Wilmoth, Ralph
AU - Griffin, Vivian
AU - Higgins, Emily
AU - MacMaster, Karen
AU - Wolverton, Marcia
AU - Rehman, Hafeez
AU - Padgett, Paige
AU - Bingham, Trista
AU - Sey, Ekow Kwa
AU - LaLota, Marlene
AU - Metsch, Lisa
AU - Forrest, David
AU - Anderson, Bridget J.
AU - Watson, Carol Ann
AU - Smith, Lou
AU - Gruber, De Ann
AU - Robinson, William T.
AU - Barak, Narquis
AU - Neai-gus, Alan
AU - Reilly, Kathleen H.
AU - Wendel, Travis
AU - Bolden, Barbara
AU - Wogayehu, Afework
AU - Godette, Henry
AU - Brady, Kathleen A.
AU - Sifferman, Andrea
AU - Miguelino-Keasling, Vanessa
AU - Velasco, Al
AU - Tovar, Veronica
AU - Raymond, H. Fisher
AU - De León, Sandra Miranda
N1 - Publisher Copyright:
© 2014.
PY - 2014/11/12
Y1 - 2014/11/12
N2 - Men who have sex with men (MSM) are at high risk for disease associated with human papillomavirus (HPV). In late 2011, HPV vaccine was recommended for males through age 21 and MSM through age 26. Using data from the 2011 National HIV Behavioral Surveillance System, we assessed self-reported HPV vaccine uptake among MSM, using multivariate analysis to calculate adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs). Among 3221 MSM aged 18-26, 157 (4.9%) reported ≥1 vaccine dose. Uptake was higher among men who visited a healthcare provider (aPR 2.3, CI: 1.2-4.2), disclosed same-sex sexual attraction/behavior to a provider (aPR 2.1, CI: 1.3-3.3), reported a positive HIV test (aPR 2.2, CI: 1.5-3.2), or received hepatitis vaccine (aPR 3.9, CI: 2.4-6.4). Of 3064 unvaccinated MSM, 2326 (75.9%) had visited a healthcare provider within 1 year. These national data on HPV vaccine uptake among MSM provide a baseline as vaccination recommendations are implemented.
AB - Men who have sex with men (MSM) are at high risk for disease associated with human papillomavirus (HPV). In late 2011, HPV vaccine was recommended for males through age 21 and MSM through age 26. Using data from the 2011 National HIV Behavioral Surveillance System, we assessed self-reported HPV vaccine uptake among MSM, using multivariate analysis to calculate adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs). Among 3221 MSM aged 18-26, 157 (4.9%) reported ≥1 vaccine dose. Uptake was higher among men who visited a healthcare provider (aPR 2.3, CI: 1.2-4.2), disclosed same-sex sexual attraction/behavior to a provider (aPR 2.1, CI: 1.3-3.3), reported a positive HIV test (aPR 2.2, CI: 1.5-3.2), or received hepatitis vaccine (aPR 3.9, CI: 2.4-6.4). Of 3064 unvaccinated MSM, 2326 (75.9%) had visited a healthcare provider within 1 year. These national data on HPV vaccine uptake among MSM provide a baseline as vaccination recommendations are implemented.
UR - http://www.scopus.com/inward/record.url?scp=84908620131&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84908620131&partnerID=8YFLogxK
U2 - 10.1016/j.vaccine.2014.09.033
DO - 10.1016/j.vaccine.2014.09.033
M3 - Article
C2 - 25258097
AN - SCOPUS:84908620131
SN - 0264-410X
VL - 32
SP - 6356
EP - 6359
JO - Vaccine
JF - Vaccine
IS - 48
ER -
